Medical Dermatology
Conference Coverage
LLDAS shows potential as routine lupus treatment target
Video
Baricitinib shows potential as lupus treatment
Make the Diagnosis
Make the Diagnosis - June 2018
A 38-year-old woman presents with numerous cystic nodules on her trunk, buttocks, and upper extremities. What’s the diagnosis?
Conference Coverage
Pemphigus remission rate tops 80% with rituximab
ORLANDO – “Rituximab is quickly emerging as frontline therapy” for pemphigus.
Conference Coverage
Long-term follow-up most important for hydroxychloroquine retinal screening
LIVERPOOL, ENGLAND – The cost of early screening for hydroxychloroquine eye toxicity is likely to be substantial if recent U.K. guidelines are...
Latest News
Cutaneous lupus: Switching antimalarials can delay immunosuppressive therapy
ORLANDO – A recent study of patients with cutaneous lupus found that about half of hydroxychloroquine nonresponders did respond to chloroquine.
Conference Coverage
Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
Indeterminate test results can exclude patients from treatment with immunosuppressives and clinical trials.
Latest News
Timely dermatomyositis diagnosis, treatment remain elusive
Increased risk of cancer in DM, especially within 1-2 years of symptom onset, is the strongest argument for earlier diagnosis.
From the Journals
Dermatologic complaints prolong hospital stay for hematologic cancer
The results of the retrospective chart review support increased attention to dermatologic complications in cancer.
Conference Coverage
Caution crucial for stem cell transplant in scleroderma, despite potential interest
Long-term success of stem cell transplant in severe scleroderma patients might prompt patient interest, but most won’t be eligible, an expert says...
Conference Coverage
New agents may bring hope for SLE patients
SANDESTIN, FLA. – Dr. Michelle Petri describes promising drugs under investigation and goals for drug treatment for different patients with SLE....